Departement of Anaesthesiology and Intensive Care, Edouard Heriot Hospital, HCL
Lyon, 69003, France
NCT Number: NCT01640613
The aim of this study is to describe technique, efficiency, safety and satisfaction of ultrasound guided intermediate cervical plexus block for carotid endarterectomy.
The investigators present a simple approach for carotid regional anaesthesia by an anterior way that has not been published yet.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lyon, 69003, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: surgery time
Time frame: surgery time
intraoperative supplementation by the surgeon
Time frame: surgery time
In case of incontrolled pain : administration of remifentanil
Time frame: anaesthesia time
hoarseness, Horner syndrome, cough, facial palsy
Time frame: after surgery
Time frame: surgery time
In case of uncontrolled pain : administration of remifentanil
Hôpital Edouard Herriot
Other
Anterior Approach Ultrasound-guided Intermediate Cervical Plexus Block for Carotid Endarterectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03982420
Arterial Occlusive Diseases, Brain Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT04053166
Brain Diseases, Cardiovascular Diseases
Bron, France
View Trial DetailsNCT04470687
Arterial Occlusive Diseases, Atheroma; Carotid Artery
Paris, France
View Trial DetailsNCT03871725
Brain Diseases, Cardiovascular Diseases
Harbin, Heilongjiang, China
View Trial Details